Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Phreesia reported revenue of $102.12 million for the quarter ended July 2024, a year-over-year increase of 19% and a surprise of +0.35% over the Zacks Consensus Estimate of $101.76 million [1] - The company posted an EPS of -$0.31, improving from -$0.68 a year ago, with an EPS surprise of +16.22% compared to the consensus estimate of -$0.37 [1] Revenue Metrics - Average healthcare services clients reached 4,169, slightly above the average estimate of 4,159 based on three analysts [3] - Patient payment volume was reported at $1.09 billion, below the average estimate of $1.13 billion from three analysts [4] - Average revenue per healthcare services client was $17.73 million, compared to the two-analyst average estimate of $18.20 million [5] Segment Revenue Performance - Subscription and related services revenue was $48.61 million, exceeding the average estimate of $47.93 million based on six analysts, representing a year-over-year change of +23.7% [6] - Network solutions revenue was $28.20 million, slightly above the six-analyst average estimate of $28.06 million, with a year-over-year change of +23.2% [7] - Payment processing fees revenue was $25.30 million, below the average estimate of $25.76 million from six analysts, reflecting a year-over-year change of +7.1% [8] Stock Performance - Phreesia shares have returned +4.5% over the past month, outperforming the Zacks S&P 500 composite's +3.6% change [8] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [8]